|
|
|
Volumn 27 Suppl 2, Issue , 2000, Pages 310-314
|
|
Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DACARBAZINE;
INTERLEUKIN 2;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
MALE;
MELANOMA;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PILOT STUDY;
RANDOMIZED CONTROLLED TRIAL;
SKIN TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DACARBAZINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
INTERLEUKIN-2;
MALE;
MELANOMA;
MIDDLE AGED;
PILOT PROJECTS;
SKIN NEOPLASMS;
|
|
EID: 0034182542
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
